Predictors of De-novo Development of Obstructive Sleep Apnea in Pregnancy

Sponsor
The Miriam Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02917876
Collaborator
Brown University (Other), Rhode Island Hospital (Other), Women and Infants Hospital of Rhode Island (Other)
450
1
73.9
6.1

Study Details

Study Description

Brief Summary

This study seeks to understand the physical, physiologic and biologic features that predispose a woman to the development of obstructive sleep apnea once they are exposed to the cardiopulmonary and metabolic physiological changes of pregnancy. Knowing these specific predictive factors can help identify a population at risk and guide clinicians to develop suitable targeting screening strategies.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Patients will be recruited from multiple community and hospital-based practices that care for pregnant women. Subjects will have:

    1. measurements of body composition

    2. anthropometric measures

    3. sleep and mood questionnaires

    4. Home sleep studies

    5. blood testing for biological markers

    6. salivary testing for hormonal markers

    7. pulmonary function tests and upper airway patency measurements

    Women without sleep apnea at enrollment will then be followed longitudinally for the development of obstructive sleep apnea during pregnancy with repeat assessment during their third trimester. Women diagnosed with sleep apnea at enrollment will have no further assessment in late pregnancy.

    Monetary incentives will also be issued at data collection points. Subjects will receive small gift incentives such as baby-related items.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    450 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Predictors of De-novo Development of Obstructive Sleep Apnea in Pregnancy
    Study Start Date :
    Nov 1, 2016
    Anticipated Primary Completion Date :
    Dec 30, 2022
    Anticipated Study Completion Date :
    Dec 30, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Characteristics of participants who develop obstructive sleep apnea defined as an apnea hypopnea index >5 events per hour [Up to 40 weeks]

      The study will develop a model of biologic, physiologic and anthropometric measures that predict the development of obstructive sleep apnea apnea later in pregnancy compared to baseline in early pregnancy.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • <13 completed weeks of gestation

    • BMI >30 kg/m2 at recruitment

    • 18 years of age

    • Ability to give informed consent

    Exclusion Criteria:
    • Unable to meet inclusion criteria

    • Twin pregnancies

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The Miriam Hospital Providence Rhode Island United States 02904

    Sponsors and Collaborators

    • The Miriam Hospital
    • Brown University
    • Rhode Island Hospital
    • Women and Infants Hospital of Rhode Island

    Investigators

    • Principal Investigator: Ghada Bourjeily, MD, The Miriam Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ghada Bourjeily, Associate Professor of Medicine, The Miriam Hospital
    ClinicalTrials.gov Identifier:
    NCT02917876
    Other Study ID Numbers:
    • 1R01HL130702
    First Posted:
    Sep 28, 2016
    Last Update Posted:
    Aug 2, 2022
    Last Verified:
    Jul 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Keywords provided by Ghada Bourjeily, Associate Professor of Medicine, The Miriam Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 2, 2022